Literature DB >> 33392036

Optical coherence tomography for the early detection of colorectal dysplasia and cancer: validation in a murine model.

Jian Ding1, Qiu Li1, Jiewen Lin2, Shanshan He1, Weiqiang Chen2, Qiyong He1, Qiukun Zhang2, Jintong Chen1, Ting Wu1, Shuncong Zhong2, Dan Li3.   

Abstract

BACKGROUND: There is an urgent need to develop a non-invasive imaging technique for detecting colorectal dysplasia and cancer. Technology for early and real-time microscopic assessments to select the most representative biopsy sites would also be of clinical value. In this study, we explored the sensitivity of optical coherence tomography (OCT) in detecting local lesions to demonstrate its potential for the early detection of colorectal dysplasia and cancer.
METHODS: An azoxymethane/dextran sodium sulfate mouse model of colorectal carcinogenesis was utilized. Mice were imaged by OCT, and colorectal tissue sections were observed with hematoxylin and eosin staining. The results of the parallel analyses were compared to evaluate the performance of OCT in imaging and early screening of colorectal lesions.
RESULTS: Dysplasia and cancer could be distinguished from normal colon tissues based on the OCT images. However, simple morphological changes observed in the OCT images were not sufficient to distinguish different degrees of dysplasia or distinguish dysplasia from cancerous tissues. The Youden index and diagnostic efficiency of OCT for colorectal dysplasia and cancer were 62.50% and 82.14%, respectively, while the sensitivity and specificity were 87.50% and 75.00%, respectively. Further, the positive and negative predictive values were 82.35% and 81.82%, respectively.
CONCLUSIONS: Based on our findings, we predict that OCT is a promising non-invasive imaging technique that can offer excellent positive detection rates and diagnostic accuracy for early colorectal dysplasia and cancer. This technique is expected to be valuable in realizing real-time qualitative analysis and guided targeted biopsy. 2021 Quantitative Imaging in Medicine and Surgery. All rights reserved.

Entities:  

Keywords:  Hematoxylin-eosin staining (HE staining); colorectal carcinoma; dysplasia; tomography, optical coherence

Year:  2021        PMID: 33392036      PMCID: PMC7719940          DOI: 10.21037/qims-20-13

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  22 in total

1.  Feasibility of optical coherence tomography for high-resolution imaging of human gastrointestinal tract malignancies.

Authors:  C Pitris; C Jesser; S A Boppart; D Stamper; M E Brezinski; J G Fujimoto
Journal:  J Gastroenterol       Date:  2000       Impact factor: 7.527

2.  High-resolution cross-sectional imaging of the gastrointestinal tract using optical coherence tomography: preliminary results.

Authors:  K Kobayashi; J A Izatt; M D Kulkarni; J Willis; M V Sivak
Journal:  Gastrointest Endosc       Date:  1998-06       Impact factor: 9.427

3.  Real-time epidural anesthesia guidance using optical coherence tomography needle probe.

Authors:  Qinggong Tang; Chia-Pin Liang; Kyle Wu; Anthony Sandler; Yu Chen
Journal:  Quant Imaging Med Surg       Date:  2015-02

Review 4.  A guide to multimodal endoscopy imaging for gastrointestinal malignancy - an early indicator.

Authors:  Arthur Hoffman; Henrik Manner; Johannes W Rey; Ralf Kiesslich
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-06-14       Impact factor: 46.802

5.  Detection of extracellular matrix modification in cancer models with inverse spectroscopic optical coherence tomography.

Authors:  Graham L C Spicer; Samira M Azarin; Ji Yi; Scott T Young; Ronald Ellis; Greta M Bauer; Lonnie D Shea; Vadim Backman
Journal:  Phys Med Biol       Date:  2016-09-12       Impact factor: 3.609

6.  Criteria for the diagnosis of dysplasia by endoscopic optical coherence tomography.

Authors:  Patrick R Pfau; Michael V Sivak; Amitabh Chak; Margaret Kinnard; Richard C K Wong; Gerard A Isenberg; Joseph A Izatt; Andrew Rollins; Volker Westphal
Journal:  Gastrointest Endosc       Date:  2003-08       Impact factor: 9.427

Review 7.  Optical coherence tomography for precision brain imaging, neurosurgical guidance and minimally invasive theranostics.

Authors:  Yingwei Fan; Yan Xia; Xinran Zhang; Yu Sun; Jie Tang; Liwei Zhang; Hongen Liao
Journal:  Biosci Trends       Date:  2018-01-15       Impact factor: 2.400

8.  Optical coherence tomography correlates multiple measures of tissue damage following acute burn injury.

Authors:  Anthony J Deegan; Samuel P Mandell; Ruikang K Wang
Journal:  Quant Imaging Med Surg       Date:  2019-05

9.  Fluorescence-guided optical coherence tomography imaging for colon cancer screening: a preliminary mouse study.

Authors:  Nicusor Iftimia; Arun K Iyer; Daniel X Hammer; Niyom Lue; Mircea Mujat; Martha Pitman; R Daniel Ferguson; Mansoor Amiji
Journal:  Biomed Opt Express       Date:  2011-12-19       Impact factor: 3.732

10.  Comparison of optical coherence tomography angiography and narrow-band imaging using a bimodal endoscope.

Authors:  Lara M Wurster; Simon Kretschmer; Jan Jäger; Fabian Placzek; Laurin Ginner; Wolfgang Drexler; Çağlar Ataman; Rainer A Leitgeb; Hans Zappe
Journal:  J Biomed Opt       Date:  2019-09       Impact factor: 3.170

View more
  3 in total

1.  Differential diagnosis of acute and chronic colitis in mice by optical coherence tomography.

Authors:  Dan Li; Shijie Ding; Manting Luo; Jinguo Chen; Qiukun Zhang; Yijuan Liu; Anlan Li; Shuncong Zhong; Jian Ding
Journal:  Quant Imaging Med Surg       Date:  2022-06

2.  A pilot and ex-vivo study of examination of endometrium tissue by catheter based optical coherence tomography.

Authors:  Bo Ding; Tao Jinyuan; Kuiyuan Tao; Zhenyang Ding; Shen Yang
Journal:  BMC Med Imaging       Date:  2022-09-10       Impact factor: 2.795

Review 3.  Research progress on the application of optical coherence tomography in the field of oncology.

Authors:  Linhai Yang; Yulun Chen; Shuting Ling; Jing Wang; Guangxing Wang; Bei Zhang; Hengyu Zhao; Qingliang Zhao; Jingsong Mao
Journal:  Front Oncol       Date:  2022-07-25       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.